DK1131301T3 - 2-phenylbenzimidazoler og 2-phenylindoler, fremstilling af anvendelse heraf - Google Patents

2-phenylbenzimidazoler og 2-phenylindoler, fremstilling af anvendelse heraf

Info

Publication number: DK1131301T3
Authority: DK; Denmark
Prior art keywords: phenylbenzimidazoles; phenylindoles; preparation
Prior art date: 1998-11-17

Application number

DK99972206T

Other languages

Danish (da)

English (en)

Inventor

Wilfried Lubisch

Michael Kock

Thomas Hoeger

Original Assignee

Abbott Gmbh & Co Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-17

Filing date

1999-11-05

Publication date

2006-01-09

1999-11-05 Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg

2006-01-09 Application granted granted Critical

2006-01-09 Publication of DK1131301T3 publication Critical patent/DK1131301T3/da

Links

KLLLJCACIRKBDT-UHFFFAOYSA-N 2-phenyl-1H-indole Chemical class N1C2=CC=CC=C2C=C1C1=CC=CC=C1 KLLLJCACIRKBDT-UHFFFAOYSA-N 0.000 title 1
DWYHDSLIWMUSOO-UHFFFAOYSA-N 2-phenyl-1h-benzimidazole Chemical class C1=CC=CC=C1C1=NC2=CC=CC=C2N1 DWYHDSLIWMUSOO-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Diabetes (AREA)
Oncology (AREA)
Immunology (AREA)
Hematology (AREA)
Cardiology (AREA)
Communicable Diseases (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Psychiatry (AREA)
Obesity (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

DK99972206T 1998-11-17 1999-11-05 2-phenylbenzimidazoler og 2-phenylindoler, fremstilling af anvendelse heraf DK1131301T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19852816		1998-11-17

Publications (1)

Publication Number	Publication Date
DK1131301T3 true DK1131301T3 (da)	2006-01-09

Family

ID=7887971

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK99972206T DK1131301T3 (da)	1998-11-17	1999-11-05	2-phenylbenzimidazoler og 2-phenylindoler, fremstilling af anvendelse heraf

Country Status (30)

Country	Link
US (1)	US6509365B1 (id)
EP (1)	EP1131301B1 (id)
JP (2)	JP2002529537A (id)
KR (1)	KR20010080474A (id)
CN (1)	CN1331683A (id)
AR (1)	AR021297A1 (id)
AT (1)	ATE302758T1 (id)
AU (1)	AU755694B2 (id)
BG (1)	BG105550A (id)
BR (1)	BR9915381A (id)
CA (1)	CA2350734C (id)
CO (1)	CO5140115A1 (id)
CZ (1)	CZ20011724A3 (id)
DE (1)	DE59912473D1 (id)
DK (1)	DK1131301T3 (id)
ES (1)	ES2247867T3 (id)
HK (1)	HK1041694A1 (id)
HR (1)	HRP20010451A2 (id)
HU (1)	HUP0104129A3 (id)
ID (1)	ID28846A (id)
IL (1)	IL143102A0 (id)
NO (1)	NO20012419L (id)
PL (1)	PL347684A1 (id)
RU (1)	RU2001116581A (id)
SI (1)	SI1131301T1 (id)
SK (1)	SK6742001A3 (id)
TR (1)	TR200101400T2 (id)
TW (1)	TW460466B (id)
WO (1)	WO2000029384A1 (id)
ZA (1)	ZA200103834B (id)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6919366B2 (en) *	1998-05-22	2005-07-19	Avanir Pharmaceuticals	Benzimidazole derivatives as modulators of IgE
US6911462B2 (en) *	1998-05-22	2005-06-28	Avanir Pharmaceuticals	Benzimidazole compounds for regulating IgE
HUP0200312A3 (en)	1998-11-03	2002-12-28	Basf Ag	Substituted 2-phenylbenzimidazoles, pharmaceutical compositions containing them, the production thereof and their use
DE19920936A1 (de) *	1999-05-07	2000-11-09	Basf Ag	Heterozyklisch substituierte Benzimidazole, deren Herstellung und Anwendung
US6759425B2 (en)	1999-10-21	2004-07-06	Avanir Pharmaceuticals	Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
DE10022925A1 (de) *	2000-05-11	2001-11-15	Basf Ag	Substituierte Indole als PARP-Inhibitoren
EP1368028B1 (en) *	2001-03-12	2007-08-15	Avanir Pharmaceuticals	Benzimidazole compounds for modulating ige and inhibiting cellular proliferation
TW200304820A (en) *	2002-03-25	2003-10-16	Avanir Pharmaceuticals	Use of benzimidazole analogs in the treatment of cell proliferation
DE50310378D1 (de)	2002-07-26	2008-10-02	Basf Plant Science Gmbh	Neue selektionsverfahren
WO2004024655A2 (en)	2002-09-12	2004-03-25	Avanir Pharmaceuticals	Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation
TWI276631B (en)	2002-09-12	2007-03-21	Avanir Pharmaceuticals	Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
US7179832B2 (en) *	2003-01-23	2007-02-20	Crystalgenomics, Inc.	Glycogen synthase kinase 3β inhibitor, composition and process for the preparation thereof
US20050256179A1 (en) *	2003-08-08	2005-11-17	Sircar Jagadish C	Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases
US7781478B2 (en)	2004-07-14	2010-08-24	Ptc Therapeutics, Inc.	Methods for treating hepatitis C
CN100431606C (zh) *	2004-11-22	2008-11-12	山东蓝金生物工程有限公司	一种抗癌药物组合物
AU2006222012B2 (en)	2005-03-08	2011-03-31	Basf Plant Science Gmbh	Expression enhancing intron sequences
US7728026B2 (en)	2005-04-11	2010-06-01	Abbott Laboratories, Inc.	2-substituted-1 h-benzimidazile-4-carboxamides are PARP inhibitors
TWI375673B (en) *	2005-04-11	2012-11-01	Abbott Lab	1h-benzimidazole-4-carboxamides substituted with a quaternary carbon at the 2-position are potent parp inhibitors
EP1957477B1 (en) *	2005-09-29	2011-12-07	Abbott Laboratories	1h-benzimidazole-4-carboxamides substituted with phenyl at the 2-position are potent parp inhibitors
WO2007059230A2 (en)	2005-11-15	2007-05-24	Abbott Laboratories	Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
WO2007113596A1 (en) *	2006-04-03	2007-10-11	Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa	Amide substituted indazole and benzotriazole derivatives as poly(adp-ribose)polymerase (parp) inhibitors
CN101511821B (zh) *	2006-05-02	2013-07-17	Abbvie公司	取代的1h-苯并咪唑-4-羧酰胺类化合物是有效的parp抑制剂
KR101591656B1 (ko)	2007-01-10	2016-02-19	엠에스디 이탈리아 에스.알.엘.	폴리(ａｄｐ-리보오스) 폴리머라아제(ｐａｒｐ) 억제제로서의 아미드 치환된 인다졸
US8067613B2 (en)	2007-07-16	2011-11-29	Abbott Laboratories	Benzimidazole poly(ADP ribose)polymerase inhibitors
US7816540B2 (en) *	2007-12-21	2010-10-19	Hoffmann-La Roche Inc.	Carboxyl- or hydroxyl-substituted benzimidazole derivatives
RU2495035C2 (ru)	2008-01-08	2013-10-10	Мерк Шарп Энд Домэ Лтд	Фармацевтически приемлемые соли 2-{4-[(3s)-пиперидин-3-ил]фенил}-2н-индазол-7-карбоксамида
WO2010083199A1 (en) *	2009-01-19	2010-07-22	Abbott Laboratories	Benzthiazole inhibitors of poly(adp-ribose)polymerase
AU2010325563B2 (en)	2009-11-27	2017-02-02	Basf Plant Science Company Gmbh	Chimeric endonucleases and uses thereof
JP5944320B2 (ja)	2009-11-27	2016-07-05	ビーエーエスエフプラントサイエンスカンパニーゲーエムベーハー	最適化エンドヌクレアーゼおよびその使用
EP2504430A4 (en)	2009-11-27	2013-06-05	Basf Plant Science Co Gmbh	CHIMERIC ENDONUCLEASES AND USES THEREOF
ES2523503T3 (es)	2010-03-04	2014-11-26	Bayer Intellectual Property Gmbh	2-Amidobencimidazoles sustituidos con fluoroalquilo y su uso para el aumento de la tolerancia al estrés en plantas
EP2561759A1 (en)	2011-08-26	2013-02-27	Bayer Cropscience AG	Fluoroalkyl-substituted 2-amidobenzimidazoles and their effect on plant growth
CN103242273B (zh) *	2012-02-09	2015-06-03	中国科学院上海药物研究所	2-芳基苯并呋喃-7-甲酰胺类化合物、其制备方法及用途
CN102627620B (zh) *	2012-04-10	2015-12-16	江苏先声药物研究有限公司	一类苯并呋喃衍生物及其医药应用
WO2014037340A1 (de)	2012-09-05	2014-03-13	Bayer Cropscience Ag	Verwendung substituierter 2-amidobenzimidazole, 2-amidobenzoxazole und 2-amidobenzothiazole oder deren salze als wirkstoffe gegen abiotischen pflanzenstress
CN104230896A (zh) *	2013-06-17	2014-12-24	上海汇伦生命科技有限公司	苯并咪唑-2-哌嗪杂环类化合物、其药物组合物及其制备方法和用途
WO2017156350A1 (en)	2016-03-09	2017-09-14	K-Gen, Inc.	Methods of cancer treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3522230A1 (de) *	1985-06-21	1987-01-02	Thomae Gmbh Dr K	Neue 2-arylimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4304455A1 (de) *	1993-02-15	1994-08-18	Bayer Ag	Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate
KR100447539B1 (ko) *	1995-08-02	2004-11-10	뉴캐슬 유니버시티 벤처스 리미티드	벤조이미다졸화합물과이를포함하는제약학적조성물및이화합물을이용한치료방법
AU4054197A (en) *	1996-08-14	1998-03-06	Warner-Lambert Company	2-phenyl benzimidazole derivatives as mcp-1 antagonists

1999
- 1999-11-05 DE DE59912473T patent/DE59912473D1/de not_active Expired - Lifetime
- 1999-11-05 HU HU0104129A patent/HUP0104129A3/hu unknown
- 1999-11-05 US US09/856,036 patent/US6509365B1/en not_active Expired - Lifetime
- 1999-11-05 CN CN99814810A patent/CN1331683A/zh active Pending
- 1999-11-05 TR TR2001/01400T patent/TR200101400T2/xx unknown
- 1999-11-05 KR KR1020017006235A patent/KR20010080474A/ko not_active Application Discontinuation
- 1999-11-05 PL PL99347684A patent/PL347684A1/xx not_active Application Discontinuation
- 1999-11-05 CA CA002350734A patent/CA2350734C/en not_active Expired - Fee Related
- 1999-11-05 SI SI9930835T patent/SI1131301T1/sl unknown
- 1999-11-05 AT AT99972206T patent/ATE302758T1/de not_active IP Right Cessation
- 1999-11-05 JP JP2000582371A patent/JP2002529537A/ja active Pending
- 1999-11-05 ES ES99972206T patent/ES2247867T3/es not_active Expired - Lifetime
- 1999-11-05 ID IDW00200101197A patent/ID28846A/id unknown
- 1999-11-05 DK DK99972206T patent/DK1131301T3/da active
- 1999-11-05 AU AU13798/00A patent/AU755694B2/en not_active Ceased
- 1999-11-05 CZ CZ20011724A patent/CZ20011724A3/cs unknown
- 1999-11-05 EP EP99972206A patent/EP1131301B1/de not_active Expired - Lifetime
- 1999-11-05 SK SK674-2001A patent/SK6742001A3/sk unknown
- 1999-11-05 IL IL14310299A patent/IL143102A0/xx unknown
- 1999-11-05 WO PCT/EP1999/008466 patent/WO2000029384A1/de not_active Application Discontinuation
- 1999-11-05 RU RU2001116581/04A patent/RU2001116581A/ru unknown
- 1999-11-05 BR BR9915381-5A patent/BR9915381A/pt not_active IP Right Cessation
- 1999-11-17 AR ARP990105835A patent/AR021297A1/es unknown
- 1999-11-17 TW TW088120025A patent/TW460466B/zh not_active IP Right Cessation
- 1999-11-17 CO CO99072377A patent/CO5140115A1/es unknown
2001
- 2001-05-11 ZA ZA200103834A patent/ZA200103834B/en unknown
- 2001-05-16 NO NO20012419A patent/NO20012419L/no not_active Application Discontinuation
- 2001-05-30 BG BG105550A patent/BG105550A/xx unknown
- 2001-06-15 HR HR20010451A patent/HRP20010451A2/hr not_active Application Discontinuation
2002
- 2002-05-03 HK HK02103331.0A patent/HK1041694A1/zh unknown
2008
- 2008-11-06 JP JP2008285818A patent/JP2009120609A/ja active Pending

Also Published As

Publication number	Publication date
AR021297A1 (es)	2002-07-03
AU755694B2 (en)	2002-12-19
HK1041694A1 (zh)	2002-07-19
BR9915381A (pt)	2001-08-14
CZ20011724A3 (cs)	2001-08-15
SK6742001A3 (en)	2001-12-03
HUP0104129A2 (hu)	2002-05-29
EP1131301A1 (de)	2001-09-12
CO5140115A1 (es)	2002-03-22
HRP20010451A2 (en)	2003-04-30
ATE302758T1 (de)	2005-09-15
TW460466B (en)	2001-10-21
TR200101400T2 (tr)	2001-11-21
ES2247867T3 (es)	2006-03-01
ZA200103834B (en)	2002-05-13
HUP0104129A3 (en)	2002-09-30
CA2350734C (en)	2006-10-10
AU1379800A (en)	2000-06-05
JP2009120609A (ja)	2009-06-04
NO20012419L (no)	2001-07-12
DE59912473D1 (de)	2005-09-29
SI1131301T1 (sl)	2006-02-28
ID28846A (id)	2001-07-05
NO20012419D0 (no)	2001-05-16
US6509365B1 (en)	2003-01-21
JP2002529537A (ja)	2002-09-10
EP1131301B1 (de)	2005-08-24
CN1331683A (zh)	2002-01-16
PL347684A1 (en)	2002-04-22
WO2000029384A1 (de)	2000-05-25
IL143102A0 (en)	2002-04-21
CA2350734A1 (en)	2000-05-25
RU2001116581A (ru)	2004-02-20
KR20010080474A (ko)	2001-08-22
BG105550A (en)	2001-12-31

Publication	Publication Date	Title
DK1131301T3 (da)	2006-01-09	2-phenylbenzimidazoler og 2-phenylindoler, fremstilling af anvendelse heraf
NO20021449D0 (no)	2002-03-22	Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
NO20011956L (no)	2001-04-20	Substituerte fenylderivater, deres fremstilling og anvendelse
DK1454907T3 (da)	2009-03-09	Quninazolin og pyridopyrmidin-derivativer
TR199900531A3 (tr)	1999-10-21	Pirazolopirimidinler ve pirazolotriazinler.
PT1177178E (pt)	2005-05-31	Benzimidazois hetereciclicos substituidos, sua preparacao e aplicacao
NO20000627D0 (no)	2000-02-08	ForhÕndsbelagte kontrollert - frigjørings - gjødningsmidler og fremgangsmÕter for deres fremstilling
DE69930846D1 (de)	2006-05-24	Mehrkonfiguration-rückwand
NO20012567D0 (no)	2001-05-25	Azepinoindolderivater, fremstilling og anvendelse derav
DK1073672T3 (da)	2003-12-08	Antipicornavirale forbindelser, deres fremstilling og anvendelse
NO20006138D0 (no)	2000-12-01	Substituerte indolinoner, fremstilling og anvendelse derav som medikamenter
IS5942A (is)	2001-05-15	3,3-bíarýlpíperidín og 2,2-bíarýlmorfólín afleiður
FR2774599B1 (fr)	2001-10-05	Cataplasme
NO20005502D0 (no)	2000-11-01	Polymerer og deres anvendelse
DE69840421D1 (de)	2009-02-12	Teilnehmerkontextes
NO20006479D0 (no)	2000-12-19	Tienopyridinforbindelser, deres fremstilling og anvendelse
NO996156L (no)	2000-06-15	Substituerte cykloheptener, deres fremstilling og anvendelse
NO20012802D0 (no)	2001-06-07	Benzofuranderivater, deres fremstilling og anvendelse
DK1043306T3 (da)	2004-07-05	3-amino-3-arylpropan-1-ol-derivater, fremstilling og anvendelse af disse
NO982242D0 (no)	1998-05-15	Heparinanaloge kopolymerer, deres fremstilling og anvendelse
DE29802218U1 (de)	1998-05-14	Verstellbarer Spannkeil
DK1127052T3 (da)	2005-04-18	Substituerede 2-phenylbenzimidazoler, fremstilling og anvendelse heraf
DE60005282D1 (de)	2003-10-23	Golfschlägerkopf, golfschläger und golfschlägerset
NO20011859L (no)	2001-04-11	Imidazoisokinolinforbindelser, deres sammensetninger og anvendelse
DE29807387U1 (de)	1998-08-06	Schließe